Natural Health Trends Corp. — FY 2017 Form 10-K
Business context and reporting period. The filing covers the fiscal year ended December 31, 2017; quarterly figures include the three months ended that date. Natural Health Trends sells NHT Global wellness, personal-care and lifestyle products through direct-selling members and e-commerce. The business is highly concentrated in Hong Kong-reported sales, most of which are delivered to members in China.
Financial performance and liquidity
| Metric | FY 2017 | FY 2016 |
|---|---|---|
| Net sales | $197.6 million | $287.7 million |
| Gross profit / margin | $158.9 million / 80.4% | $232.8 million / 80.9% |
| Operating income / margin | $43.1 million / 21.8% | $64.1 million / 22.3% |
| Net income / margin | $23.6 million / 12.0% | $55.1 million / 19.2% |
| Diluted earnings per share | $2.09 | $4.83 |
| Cash from operating activities | $26.6 million | $53.2 million |
FY 2017 sales fell 31%, operating income fell 33% and net income fell 57% year over year. Fourth-quarter sales were $46.1 million versus $62.3 million a year earlier; operating income was $8.7 million versus $20.0 million. The quarter recorded a net loss of $4.5 million, principally reflecting the tax-law charge described below.
At year-end, cash and cash equivalents were $135.3 million, working capital was $109.3 million and the current ratio was 3.61. Cash included $73.6 million of available-for-sale investments classified as cash equivalents; $8.7 million was held in China subject to currency controls. The filing reports no borrowings in the presented balance sheet. Cash used in investing was $0.3 million and cash used in financing was $17.2 million, all for dividends. The company paid $1.52 per share in 2017 dividends, including special dividends.
Material changes versus the prior comparable period
- Hong Kong sales decreased 34% to $174.9 million and represented 88.5% of total sales. Management attributed weakness partly to disruption around major events and logistics, alongside a decline of 26,400 active members in Hong Kong.
- Total active members decreased to 95,670 from 118,960. Sales outside Hong Kong decreased 7% overall; Europe grew 85% from a relatively small base.
- Gross margin declined 0.5 percentage points. Commissions decreased to 42.3% of sales from 43.5%, while SG&A declined in dollars but rose to 16.0% of sales from 15.0%.
- Operating cash flow halved, to $26.6 million, with lower product orders and increased member use of eWallets among the stated factors; lower inventories and inventory deposits partly offset the decline.
Outlook, commentary, risks and unusual items
- Tax item: The 2017 tax provision rose to $19.8 million from $9.0 million. The Tax Cuts and Jobs Act produced a provisional $20.7 million deemed-repatriation tax charge and a $1.0 million deferred-tax remeasurement charge, partly offset by a $3.7 million tax benefit from reversing a deferred tax liability. The repatriation-tax liability is payable over eight years; the filing states that the final tax effect remained subject to further analysis.
- Management outlook: No specific revenue or earnings guidance is provided. Management expects existing cash and operating cash flow to fund normal operations and commitments for the foreseeable future, and says it will prioritize Greater China, Southeast Asia and Europe while continuing investment in China and selected markets. Success and timing of a China direct-selling license are uncertain.
- China exposure and regulation: The company does not hold a China direct-selling license and says its Hong Kong e-commerce model and separate China retail platform comply with applicable laws. A contrary regulatory finding, new rules, or member conduct could disrupt operations or lead to penalties. Hong Kong/China concentration makes this a central business risk.
- Litigation: A securities class action concerning alleged misstatements about China operations had a proposed $1.75 million insurer-funded settlement awaiting final court approval. Derivative claims had a tentative settlement involving governance reforms and up to $250,000 in insurer-funded attorneys’ fees, also subject to court approval. The company disputes the allegations.
- Controls and audit: Management and the auditor identified a material weakness in IT general controls over the proprietary system used for orders, bonus-volume activity and commissions, including access and change-management controls. No material financial-statement misstatement was identified, and the financial-statement audit opinion was unqualified; the auditor gave an adverse opinion on internal control over financial reporting. Management expected remediation to be completed during 2018.
- Other risks: Each of Premium Noni Juice and Enhanced Essential Probiotics accounted for more than 10% of revenue and was sourced from a single supplier. The filing also highlights member attrition, direct-selling and product regulation, foreign exchange exposure, competition, cybersecurity, and limited product-liability insurance. No formal forward-looking financial targets are stated.
Most important facts for investors to verify
- Whether member counts, productivity and sales stabilize, especially in Hong Kong and China, and whether the sales decline persists.
- How the China regulatory environment develops, including the direct-selling license process and any impact on the Hong Kong-based sales model.
- Final Tax Act accounting, cash installments for the $20.7 million repatriation-tax liability, and any additional tax exposure.
- Whether the IT-controls material weakness is fully remediated and independently validated.
- Final court approval and terms of the securities and derivative settlements, and any uninsured litigation costs.
- Continued supply and demand for the two major products sourced from single suppliers, and the company’s capacity to maintain cash generation and dividends.